Paul Weiss, Latham Drive Merck's $10.8B Calif. Biotech Buy
Pharmaceutical giant Merck will acquire biotechnology company Prometheus Biosciences for a total equity value of about $10.8 billion, the companies said Sunday, in an agreement stitched together by respective legal advisers...To view the full article, register now.
Already a subscriber? Click here to view full article